INS and fatty liver disease: Reduced obesity-associated abnormalities (hepatic steatosis)Increased leptin potencyImproved hepatic insulin sensitivityEnhanced glucose tolerance and glucose homeostasisReduction in pro-inflammatory cytokinesEnhanced lipid and glucose metabolism